Aikido Pharma

Aikido Pharma


https://aikidopharma.com/

Aikido Pharma researches and develops treatment

Aikido Pharma
Aikido Pharma 2/27/2021 9:30:00 PM

Aikido Pharma researches and develops treatment prostate cancer and has secured an early investment in Convergent Therapeutics, Inc. Convergent Therapeutics, Inc. is a startup pharmaceutical company focused on developing next generation radiopharmaceutical therapy for prostate cancer and other applications. Its proprietary technology involves peptide receptor radionuclide therapy (“PRRT”) developed under the direction of Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine. For more information, visit us online or call us at 212-745-1373.

Aikido Pharma
Written by

Aikido Pharma

Post a comment